Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-26 @ 2:49 AM
Study NCT ID:
NCT00099502
Status:
COMPLETED
Last Update Posted:
2008-12-19
First Post:
2004-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-12-15
First Submit QC Date:
None
Study First Post Date:
2004-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-12-18
Last Update Post Date:
2008-12-19
Last Update Post Date Type:
ESTIMATED